Registration No. 333-00331
Registration No. 333-65139
Registration No. 333-118264
Registration No. 333-118323
Registration No. 333-118326
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
| Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-00331 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-65139 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-118264 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-118323 Post-Effective Amendment No. 1 to Form S-8 Registration Statement No. 333-118326 |
Under The Securities Act of 1933
BIOMET, INC.
(Exact Name of Registrant as Specified in Its Charter)
|
Indiana |
|
35-1418342 |
|
(State or Other Jurisdiction of Incorporation or Organization) |
|
(I.R.S. Employer Identification No.) |
|
56 East Bell Drive, Warsaw, Indiana |
|
46582 |
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
|
| ||
|
Biomet, Inc. 401(k) Profit Sharing Plan 1998 Biomet, Inc. Qualified and Non-Qualified Stock Option Plan The 2000 Equity Participation Plan of Interpore International, Inc. The Interpore Cross International 1999 Consultants Stock Option Plan 1995 Stock Option Plan Non-Qualified Stock Option Agreement with Innovative Spinal Technologies (f/k/a The Musculo-Skeletal Research Foundation) | ||
|
(Full Titles of Plans) | ||
|
|
|
|
|
Jeffrey R. Binder | ||
|
President and Chief Executive Officer | ||
|
Keane, Inc. | ||
|
56 East Bell Drive | ||
|
Warsaw, Indiana 46582 | ||
|
(Name and Address of Agent For Service) | ||
|
| ||
|
(574) 267-6639 | ||
|
(Telephone Number, Including Area Code, of Agent For Service) | ||
|
|
|
|
|
Copy to: | ||
|
Robert Davis | ||
|
Cleary Gottlieb Steen & Hamilton LLP | ||
|
One Liberty Plaza | ||
|
New York, New York 10006 | ||
|
(212) 225-2000 | ||
|
1 |
|
DEREGISTRATION OF UNSOLD SECURITIES
These Post-Effective Amendments relate to the following Registration Statements on Form S-8 of Biomet, Inc. (the “Company”) (together, the “Registration Statements”):
File No. 333-00331, pertaining to the registration of 1,000,000 common shares of the Company (“Common Shares”), which was filed with the Securities and Exchange Commission (the “SEC”) on January 22, 1996 and became effective on February 10, 1996.
File No. 333-65139, pertaining to the registration of 7,000,000 Common Shares, which was filed with the SEC and became effective on October 1, 1998.
File No. 333-118264, pertaining to the registration of 186,612 Common Shares, which was filed with the SEC and became effective on August 16, 2004.
File No. 333-118323, pertaining to the registration of 1,500,000 Common Shares and 1,500,000 Rights to purchase Common Shares, which was filed with the SEC and became effective on August 18, 2004.
File No. 333-118326, pertaining to the registration of $10,000,000 in deferred compensation obligations, which was filed with the SEC and became effective on August 18, 2004.
The offerings pursuant to these Registration Statements have been terminated. In accordance with undertakings made by the Company in the Registration Statements, the Company hereby removes from registration the securities and deferred compensation obligations of the Company registered but unsold under the Registration Statements.
|
2 |
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to be signed on its behalf by the undersigned, thereunto duly authorized, in Warsaw, Indiana, on September 24, 2007.
|
|
|
|
BIOMET, INC. | ||
|
|
|
|
|
| |
|
|
|
|
By: |
/s/ JEFFREY R. BINDER |
|
|
|
|
|
|
Jeffrey R. Binder | |
|
|
|
|
|
| |
Pursuant to the requirements of the Securities Act of 1933, these Post-Effective Amendments to the Registration Statements have been signed by the following persons in the capacities and on the dates indicated:
|
Signature |
|
Title |
|
Date |
|
|
|
|
|
|
|
/s/ JEFFREY R. BINDER |
|
President, Chief Executive Officer and Director (Principal Executive Officer) |
|
September 24, 2007 |
|
Jeffrey R. Binder |
||||
|
|
|
|
||
|
|
|
|
|
|
|
/s/ DANIEL P. FLORIN |
|
Senior Vice President and Chief Financial Officer (Principal Financial Officer) |
|
September 24, 2007 |
|
Daniel P. Florin |
|
|
| |
|
|
|
|
|
|
|
/s/ JAMES W. HALLER |
|
Controller (Principal Accounting Officer) |
|
September 24, 2007 |
|
James W. Haller |
|
|
| |
|
|
|
|
|
|
|
/s/ CHINH E. CHU |
|
Director |
|
September 24, 2007 |
|
Chinh E. Chu |
|
|
|
|
|
|
|
|
|
|
|
/s/ JONATHAN J. COSLET |
|
Director |
|
September 24, 2007 |
|
Jonathan J. Coslet |
|
|
|
|
|
|
|
|
|
|
|
/s/ MICHAEL DAL BELLO |
|
Director |
|
September 24, 2007 |
|
Michael Dal Bello |
|
|
|
|
|
|
|
|
|
|
|
/s/ SEAN FERNANDES |
|
Director |
|
September 24, 2007 |
|
Sean Fernandes |
|
|
|
|
|
|
|
|
|
|
|
/s/ ADRIAN JONES |
|
Director |
|
September 24, 2007 |
|
Adrian Jones |
|
|
|
|
|
|
|
|
|
|
|
/s/ MICHAEL MICHELSON |
|
Director |
|
September 24, 2007 |
|
Michael Michelson |
|
|
|
|
|
|
|
|
|
|
|
/s/ DANE A. MILLER |
|
Director |
|
September 24, 2007 |
|
Dane A. Miller |
|
|
|
|
|
|
|
|
|
|
|
/s/ JOHN SAER |
|
Director |
|
September 24, 2007 |
|
John Saer |
|
|
|
|
|
|
|
|
|
|
|
|
3 |
|